SCHEMBL6993379

SCHEMBL6993379

CC(=O)N(C)NC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 8/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
EPHX2 P34913 3/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 1/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MMP2 P08253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3263337 0.74 PKM (0.36) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
SCHEMBL3687898 0.72 NPSR1 (0.38) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
SCHEMBL319749 0.71 ALDH1A1 (0.45) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
Acetone SCHEMBL20551274 0.69 ALDH1A1 (0.67) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
Ammonia Solution, Strong SCHEMBL22685960 0.69 ALDH1A1 (0.43) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
SCHEMBL6069315 0.68
SCHEMBL13579152 0.67 NPSR1 (0.51) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
SCHEMBL3038208 0.67 EPHX1 (0.64) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
SCHEMBL16317726 0.67 EPHX1 (0.64) EPHX1NPC1RAB9ASMN1; SMN2EPHX2
SCHEMBL16317723 0.67 EPHX1 (0.64) EPHX1NPC1RAB9ASMN1; SMN2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP disclosed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
US-5821240-A ENZYME INHIBITORS, SIGNAL INHIBITORS FOR ANTIINFLAMMATORY AGENTS, ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS AND HORMONE INHIBITORS DR. KARL THOMAE GMBH (DE) 1998-10-13 US disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed